India to Australia: Fenofibrate Export Trade Route

The India to Australia Fenofibrate corridor is one of India's established pharmaceutical export routes, with 85 shipments documented worth a combined $6.0M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 41% of all export value, reflecting the consolidated nature of India's fenofibrate manufacturing sector.

Across 8 active suppliers, the average shipment value stands at $70.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with fenofibrate's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 29.1%, placing it at rank #15 among India's top fenofibrate export destinations globally.

On the import side, key buyers of Indian fenofibrate in Australia include ARROW PHARMACEUTICALS PTY LTD,, SANDOZ PTY LTD, TO THE ORDER and 17 others. ARROW PHARMACEUTICALS PTY LTD, is the single largest importer with 9 shipments valued at $1.9M USD.

India's fenofibrate exports to Australia are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 33 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, HETERO LABS LIMITED, HETERO LABS LIMITED — together account for 82% of total trade value on this route. The average shipment value of $70.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as fenofibrate tablet and fenofibrate tabletnos, suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ARROW PHARMACEUTICALS PTY LTD, is the largest importer with 9 shipments worth $1.9M USD — representing 32% of all fenofibrate imports from India on this route. A total of 20 buyers are active on this corridor.